A computational study to identify Sesamol derivatives as NRF2 activator for protection against drug-induced liver injury (DILI)
2023 · Molecular Diversity · 8 citations
https://doi.org/10.1007/s11030-023-10686-8
R
Richard Lobo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
111
Papers
1.3K
Citations
17
h-index
35
i10-index
Richard Lobo is an academic researcher from Manipal Academy of Higher Education. The author has contributed to research in topics: Essential Oils and Antimicrobial Activity & Ethnobotanical and Medicinal Plants Studies & Phytochemistry and Biological Activities. The author has an h-index of 17, co-authored 95 publications.
ORCID: 0000-0003-3202-1108Papers by this author
worksIn-silico and in-vivo evaluation of sesamol and its derivatives for benign prostatic hypertrophy
2021 · 3 Biotech · 2 citations
https://doi.org/10.1007/s13205-021-02952-z
Identifying the role of Phytomolecules in the management of liver diseases by modulating NRF2 pathway: A Scoping Review Protocol
2024 · F1000Research · 0 citations
https://doi.org/10.12688/f1000research.150635.2
Diosgenin-mediated NF-κB and MAPK pathway modulation for osteoarthritis treatment: molecular mechanisms, bioavailability enhancement, and therapeutic applications
2026 · Inflammopharmacology · 0 citations
https://doi.org/10.1007/s10787-025-02102-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat